PrecISE- A Biomarker Stratified Adaptive Trial of 5 Interventions in Severe Asthma: Final Protocol and the Baseline Cohort.
Denlinger LC, Israel E, Moore WC, Georas SN, Wright RJ, Castro M, Peden DB, Anstrom KJ, Bleecker ER, Alexander LC, Cahill KN, Cardet JC, Carr TF, Cedano J, Chen AY, Chupp GL, Comhair SAA, DiMango EA, Erzurum SC, Fahy JV, Fajt ML, Gaston BM, Jackson DJ, Jain S, Jarjour NN, Kenyon NJ, Kraft M, Krishnan JA, Kumar R, Lugogo NL, Martinez FD, Marquis MA, Pappalardo AA, Phipatanakul W, Rank MA, Rosenberg SR, Salciccioli JD, Sanchez M, Smith LJ, Sumino K, Szefler SJ, Tang M, Vijayanand P, Wechsler ME, Wenzel SE, White SR, Zeki AA, Ivanova A, Bacharier LB, Akuthota P; NHLBI PrecISE Study Team.
Denlinger LC, et al.
J Allergy Clin Immunol. 2026 Feb 16:S0091-6749(26)00082-5. doi: 10.1016/j.jaci.2026.02.001. Online ahead of print.
J Allergy Clin Immunol. 2026.
PMID: 41707916